These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30581043)

  • 1. Crystal Structure of CC Chemokine Receptor 2A in Complex with an Orthosteric Antagonist Provides Insights for the Design of Selective Antagonists.
    Apel AK; Cheng RKY; Tautermann CS; Brauchle M; Huang CY; Pautsch A; Hennig M; Nar H; Schnapp G
    Structure; 2019 Mar; 27(3):427-438.e5. PubMed ID: 30581043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of CC chemokine receptor 2 with orthosteric and allosteric antagonists.
    Zheng Y; Qin L; Zacarías NV; de Vries H; Han GW; Gustavsson M; Dabros M; Zhao C; Cherney RJ; Carter P; Stamos D; Abagyan R; Cherezov V; Stevens RC; IJzerman AP; Heitman LH; Tebben A; Kufareva I; Handel TM
    Nature; 2016 Dec; 540(7633):458-461. PubMed ID: 27926736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure prediction and molecular dynamics simulations of a G-protein coupled receptor: human CCR2 receptor.
    Singh R; Sobhia ME
    J Biomol Struct Dyn; 2013; 31(7):694-715. PubMed ID: 22909007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for ligand modulation of the CCR2 conformational landscape.
    Taylor BC; Lee CT; Amaro RE
    Proc Natl Acad Sci U S A; 2019 Apr; 116(17):8131-8136. PubMed ID: 30975755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elucidation of binding sites of dual antagonists in the human chemokine receptors CCR2 and CCR5.
    Hall SE; Mao A; Nicolaidou V; Finelli M; Wise EL; Nedjai B; Kanjanapangka J; Harirchian P; Chen D; Selchau V; Ribeiro S; Schyler S; Pease JE; Horuk R; Vaidehi N
    Mol Pharmacol; 2009 Jun; 75(6):1325-36. PubMed ID: 19297521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In situ crystallography as an emerging method for structure solution of membrane proteins: the case of CCR2A.
    Cheng R; Huang CY; Hennig M; Nar H; Schnapp G
    FEBS J; 2020 Mar; 287(5):866-873. PubMed ID: 31621196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arginine 313 of the putative 8th helix mediates Gα
    Markx D; Schuhholz J; Abadier M; Beier S; Lang M; Moepps B
    Cell Signal; 2019 Jan; 53():170-183. PubMed ID: 30321592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosteric and orthosteric sites in CC chemokine receptor (CCR5), a chimeric receptor approach.
    Thiele S; Steen A; Jensen PC; Mokrosinski J; Frimurer TM; Rosenkilde MM
    J Biol Chem; 2011 Oct; 286(43):37543-54. PubMed ID: 21878623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural insights from binding poses of CCR2 and CCR5 with clinically important antagonists: a combined in silico study.
    Kothandan G; Gadhe CG; Cho SJ
    PLoS One; 2012; 7(3):e32864. PubMed ID: 22479344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of trisubstituted cyclohexanes as potent CC chemokine receptor 2 (CCR2) antagonists.
    Cherney RJ; Brogan JB; Mo R; Lo YC; Yang G; Miller PB; Scherle PA; Molino BF; Carter PH; Decicco CP
    Bioorg Med Chem Lett; 2009 Feb; 19(3):597-601. PubMed ID: 19131247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural Analysis of Chemokine Receptor-Ligand Interactions.
    Arimont M; Sun SL; Leurs R; Smit M; de Esch IJP; de Graaf C
    J Med Chem; 2017 Jun; 60(12):4735-4779. PubMed ID: 28165741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and mapping of an intracellular antagonist binding site at the chemokine receptor CCR2.
    Zweemer AJ; Bunnik J; Veenhuizen M; Miraglia F; Lenselink EB; Vilums M; de Vries H; Gibert A; Thiele S; Rosenkilde MM; IJzerman AP; Heitman LH
    Mol Pharmacol; 2014 Oct; 86(4):358-68. PubMed ID: 25024169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revealing the Positive Binding Cooperativity Mechanism between the Orthosteric and the Allosteric Antagonists of CCR2 by Metadynamics and Gaussian Accelerated Molecular Dynamics Simulations.
    An X; Bai Q; Bing Z; Liu H; Zhang Q; Liu H; Yao X
    ACS Chem Neurosci; 2020 Feb; 11(4):628-637. PubMed ID: 31968162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of cancer-associated mutations in CC chemokine receptor 2 on receptor function and antagonism.
    den Hollander LS; Béquignon OJM; Wang X; van Wezel K; Broekhuis J; Gorostiola González M; de Visser KE; IJzerman AP; van Westen GJP; Heitman LH
    Biochem Pharmacol; 2023 Feb; 208():115399. PubMed ID: 36581051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and synthesis of cyclohexenyl derivatives as modulators of CC chemokine receptor 2 activity.
    Brown GD; Shi Q; Delucca GV; Batt DG; Galella MA; Cvijic ME; Liu RQ; Qiu F; Zhao Q; Barrish JC; Carter PH
    Bioorg Med Chem Lett; 2016 Jan; 26(2):662-666. PubMed ID: 26631321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyrrolone Derivatives as Intracellular Allosteric Modulators for Chemokine Receptors: Selective and Dual-Targeting Inhibitors of CC Chemokine Receptors 1 and 2.
    Ortiz Zacarías NV; van Veldhoven JPD; Portner L; van Spronsen E; Ullo S; Veenhuizen M; van der Velden WJC; Zweemer AJM; Kreekel RM; Oenema K; Lenselink EB; Heitman LH; IJzerman AP
    J Med Chem; 2018 Oct; 61(20):9146-9161. PubMed ID: 30256641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into CC Chemokine Ligand 2/Chemokine Receptor 2 Molecular Recognition: A Step Forward toward Antichemotactic Agents.
    David KS; Oliveira ERA; Horta BAC; Valente AP; de Paula VS
    Biochemistry; 2017 Jun; 56(25):3197-3210. PubMed ID: 28570817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and Characterization of an Intracellular Covalent Ligand for CC Chemokine Receptor 2.
    Ortiz Zacarías NV; Chahal KK; Šimková T; van der Horst C; Zheng Y; Inoue A; Theunissen E; Mallee L; van der Es D; Louvel J; IJzerman AP; Handel TM; Kufareva I; Heitman LH
    J Med Chem; 2021 Mar; 64(5):2608-2621. PubMed ID: 33600174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple binding sites for small-molecule antagonists at the CC chemokine receptor 2.
    Zweemer AJ; Nederpelt I; Vrieling H; Hafith S; Doornbos ML; de Vries H; Abt J; Gross R; Stamos D; Saunders J; Smit MJ; Ijzerman AP; Heitman LH
    Mol Pharmacol; 2013 Oct; 84(4):551-61. PubMed ID: 23877010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for the interaction of human β-defensin 6 and its putative chemokine receptor CCR2 and breast cancer microvesicles.
    De Paula VS; Gomes NS; Lima LG; Miyamoto CA; Monteiro RQ; Almeida FC; Valente AP
    J Mol Biol; 2013 Nov; 425(22):4479-95. PubMed ID: 23938203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.